
Enovis
Orthopedic Innovation for Life.
Wilmington, Delaware, United States
Medical technology company specializing in clinically differentiated orthopedic therapeutic solutions with brands including DonJoy, Aircast, Chattanooga, Compex, and Enovis Surgical. Operates through Prevention and Recovery segment (bracing, therapy systems, compression products) and Reconstructive segment (surgical implants for joint reconstruction).

How We Help
Problem Statement
Enovis addresses the need for improved patient outcomes, restored motion, and enhanced efficiency in healthcare workflows for the prevention, treatment, and rehabilitation of musculoskeletal, neurological, and soft tissue conditions.
Core Technology
Enovis's core technology encompasses a wide array of brands and products including Aircast®, DonJoy®, Exos®, Enovis Surgical™, and Dr. Comfort®. This portfolio includes adult reconstructive shoulder, hip, and knee implants (e.g., EMPOWR 3D Knee®, AltiVate Reverse® Shoulder system), devices for foot and ankle surgeries, innovative bracing technology, and digital workflow/engagement software like MotionMD® and MotionIQ®.
Key Differentiators
Enovis provides clinically differentiated solutions, innovative bracing technology for enhanced patient compliance, workflow software (MotionMD®) for clinic operations, and digital engagement tools (MotionIQ®) to support patients through rehabilitation.
Clinical Focus
The company's clinical focus spans the orthopedic continuum of care, including bracing & supports, surgical solutions, foot & ankle, recovery sciences, regeneration, and broader healthcare solutions for musculoskeletal conditions, as well as neurological and soft tissue disorders.
Target Customers
Patients, physicians, clinics, hospitals, and health systems.
Product Stage
Mature
Company Info
- Business Model
- Enovis operates as a medical device manufacturer and solutions provider (B2B and B2C), offering high-quality medical devices for reconstructive surgery, rehabilitation, pain management, and physical therapy. Their strategy includes continuous improvement via 'Enovis Growth Excellence (EGX)' and portfolio expansion through strategic acquisitions.
- Founded
- 2022
- Website
- enovis.com
Categories
Disease Areas
Technologies
MedStartr Index Score
?What do you think of Enovis?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.